Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical hold that ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...

Following patient deaths in a lupus trial that led to the termination of that program, Kezar’s autoimmune candidate ...

For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...